ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell... ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.01 | 0.591715976331 | 1.69 | 1.88 | 1.5 | 533302 | 1.62018879 | CS |
4 | -0.01 | -0.584795321637 | 1.71 | 1.8999 | 1.46 | 508447 | 1.71400877 | CS |
12 | -0.0744 | -4.19296663661 | 1.7744 | 2.265 | 1.41 | 480131 | 1.79431926 | CS |
26 | -0.41 | -19.4312796209 | 2.11 | 2.57 | 1.41 | 571507 | 2.05422104 | CS |
52 | 0.4 | 30.7692307692 | 1.3 | 4.44 | 1.18 | 668483 | 2.2564744 | CS |
156 | -7.7 | -81.914893617 | 9.4 | 14.19 | 1.12 | 479418 | 3.72723317 | CS |
260 | -7.7 | -81.914893617 | 9.4 | 14.19 | 1.12 | 479418 | 3.72723317 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約